Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) just unveiled an update.
OneSource Specialty Pharma Limited, a listed Indian pharmaceutical services company operating under the Onesource CDMO platform, maintains a credit rating of IND A- with a Positive outlook from India Ratings & Research, reaffirmed in December 2025. This positioning underscores its continuing access to rated debt markets and its role as a specialty pharma and contract service provider.
The company has elected to withdraw all its credit ratings from CareEdge Ratings as part of a broader rationalisation of external rating relationships, while those CARE ratings were simultaneously reaffirmed at BBB+; Stable and A3+ before withdrawal. By consolidating its rating coverage with India Ratings & Research, OneSource is simplifying its credit profile disclosures, a move that may reduce compliance complexity for the issuer while slightly lowering rating transparency for some stakeholders who relied on multiple agency views.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited operates in the pharmaceutical sector and appears to focus on contract development and manufacturing services, as suggested by its use of the Onesource CDMO brand. The company is listed on Indian stock exchanges and maintains an external credit rating from India Ratings & Research, indicating active engagement with capital markets and debt investors.
Average Trading Volume: 23,377
Technical Sentiment Signal: Strong Sell
Current Market Cap: 150.3B INR
For detailed information about ONESOURCE stock, go to TipRanks’ Stock Analysis page.